EMX Royalty Corporation (TSXV:EMX)
Canada · Delayed Price · Currency is CAD 4.540
+0.190 (4.37%)
Aug 13, 2025, 3:21 PM EDT
ShockWave Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 29.86 | 27.45 | 26.62 | 18.28 | 7.53 | 5.65 | Upgrade | |
Revenue Growth (YoY) | -8.72% | 3.11% | 45.65% | 142.85% | 33.21% | 44.14% | Upgrade |
Cost of Revenue | 9.82 | 10.98 | 10.81 | 8.64 | 7.57 | 6.62 | Upgrade |
Gross Profit | 20.04 | 16.46 | 15.82 | 9.64 | -0.05 | -0.97 | Upgrade |
Selling, General & Admin | 8.56 | 8.62 | 7.62 | 8.7 | 7.4 | 5.62 | Upgrade |
Other Operating Expenses | 0.24 | 0.24 | - | - | - | - | Upgrade |
Operating Expenses | 15.29 | 15.5 | 12.87 | 14.5 | 9.99 | 6.59 | Upgrade |
Operating Income | 4.75 | 0.96 | 2.95 | -4.86 | -10.04 | -7.55 | Upgrade |
Interest Expense | -2.87 | -3.81 | -5.09 | -5.25 | -2.1 | - | Upgrade |
Earnings From Equity Investments | 5.14 | 4.33 | 4.13 | 2.89 | 2.76 | - | Upgrade |
Currency Exchange Gain (Loss) | 0.28 | -0.6 | -1.01 | 2.06 | -3.95 | -0.14 | Upgrade |
Other Non Operating Income (Expenses) | 2.13 | 0.29 | -2.18 | 0.26 | -0.23 | - | Upgrade |
EBT Excluding Unusual Items | 9.43 | 1.17 | -1.2 | -4.9 | -13.56 | -7.69 | Upgrade |
Gain (Loss) on Sale of Investments | 3.34 | 2.05 | -1.81 | -4.11 | -4.64 | 5.03 | Upgrade |
Asset Writedown | -1.09 | -0.4 | -0.07 | -5.53 | -8.37 | - | Upgrade |
Other Unusual Items | -2.2 | -2.38 | -0.31 | 22.83 | - | - | Upgrade |
Pretax Income | 9.48 | 0.44 | -3.39 | 8.3 | -26.57 | -2.66 | Upgrade |
Income Tax Expense | 4.61 | 3.73 | 1.24 | 4.95 | -2.84 | 2.06 | Upgrade |
Net Income | 4.86 | -3.29 | -4.63 | 3.35 | -23.73 | -4.71 | Upgrade |
Net Income to Common | 4.86 | -3.29 | -4.63 | 3.35 | -23.73 | -4.71 | Upgrade |
Shares Outstanding (Basic) | 111 | 113 | 111 | 109 | 89 | 84 | Upgrade |
Shares Outstanding (Diluted) | 111 | 113 | 111 | 110 | 89 | 84 | Upgrade |
Shares Change (YoY) | -1.13% | 1.26% | 1.18% | 23.25% | 6.52% | 2.30% | Upgrade |
EPS (Basic) | 0.04 | -0.03 | -0.04 | 0.03 | -0.27 | -0.06 | Upgrade |
EPS (Diluted) | 0.04 | -0.03 | -0.04 | 0.03 | -0.27 | -0.06 | Upgrade |
Free Cash Flow | 2.96 | 3.31 | 6.89 | 16 | -8.22 | -7.16 | Upgrade |
Free Cash Flow Per Share | 0.03 | 0.03 | 0.06 | 0.15 | -0.09 | -0.09 | Upgrade |
Gross Margin | 67.11% | 59.98% | 59.41% | 52.75% | -0.64% | -17.10% | Upgrade |
Operating Margin | 15.92% | 3.51% | 11.07% | -26.60% | -133.40% | -133.67% | Upgrade |
Profit Margin | 16.28% | -11.98% | -17.40% | 18.32% | -315.32% | -83.44% | Upgrade |
Free Cash Flow Margin | 9.90% | 12.04% | 25.88% | 87.56% | -109.28% | -126.77% | Upgrade |
EBITDA | 10.83 | 7.49 | 8.17 | 0.92 | -7.54 | -6.62 | Upgrade |
EBITDA Margin | 36.26% | 27.30% | 30.68% | 5.05% | -100.20% | -117.20% | Upgrade |
D&A For EBITDA | 6.08 | 6.53 | 5.22 | 5.78 | 2.5 | 0.93 | Upgrade |
EBIT | 4.75 | 0.96 | 2.95 | -4.86 | -10.04 | -7.55 | Upgrade |
EBIT Margin | 15.92% | 3.51% | 11.07% | -26.60% | -133.40% | -133.67% | Upgrade |
Effective Tax Rate | 48.68% | 843.89% | - | 59.63% | - | - | Upgrade |
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.